Table 1—

Characteristics of the study cohort

Baseline
Follow-up
Male patientsFemale patientsMale patientsFemale patients
n43333926
Age (years)15.2 ± 2.215.3 ± 1.923.7 ± 2.123.9 ± 2.0
Duration of diabetes8.0 ± 3.77.1 ± 2.916.3 ± 3.515.7 ± 2.9
HbAlc9.4 ± 2.59.7 ± 1.89.6 ± 1.89.3 ± 1.9
BMI20.1 ± 2.422.7 ± 3.724.0 ± 2.524.7 ± 2.6
BMI SDS*0.21 ± 0.850.77 ± 0.750.29 ± 0.860.79 ± 0.75§
Complications(n = 40)(n = 29)
 Severe retinopathy0012
 Nephropathy0065
 Multiple0013
 Hypertension0021
  • Data are means ± (SD).

  • *

    * Cohort BMI standard deviation score (SDS) vs. normal population data,

  • P < 0.001,

  • P < 0.05. Severe retinopathy = laser-treated proliferative retinopathy only, nephropathy = microalbuminuria or proteinuria only, multiple = both severe retinopathy and nephropathy, hypertension = antihypertensive therapy (with no nephropathy).